| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |